Примери за използване на Azacitidine celgene на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Men should not father a child while receiving treatment with Azacitidine Celgene.
This is because Azacitidine Celgene may affect the way some other medicines work.
An overview of Azacitidine Celgene and why it is authorised in the EU.
Azacitidine Celgene is an anti-cancer agent which belongs to a group of medicines called‘antimetabolites'.
Azacitidine Celgene is available as a powder to be made up into a suspension for injection.
You should not use Azacitidine Celgene during pregnancy as it may be harmful to the baby.
For the full list of side effects and restrictions of Azacitidine Celgene, see the package leaflet.
Azacitidine Celgene was shown to be more effective than conventional care in extending survival in two main studies.
Side effects reported with Azacitidine Celgene are carefully evaluated
Azacitidine Celgene is used in patients with an intermediate to high risk of progressing to AML or death;
Children and adolescents Azacitidine Celgene is not recommended for use in children and adolescents below the age of 18.
Azacitidine Celgene is used in adults who are not able to have a stem cell transplantation to treat.
The company that makes Vidaza has agreed that its scientific data can be used for Azacitidine Celgene(‘informed consent').
The Azacitidine Celgene suspension may be prepared immediately before use
Azacitidine Celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation(HSCT) with.
patients receiving Azacitidine Celgene survived for an average of 24.5 months,
The recommended dose of Azacitidine Celgene is 75 mg per square metre body surface area(calculated using the patient's height and weight).
Before giving you Azacitidine Celgene, your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle.
The company that makes Vidaza has agreed that its scientific data can be used for Azacitidine Celgene(‘informed consent').
Azacitidine Celgene is a cytotoxic medicinal product and, as with other potentially toxic compounds, caution should be exercised when handling and preparing azacitidine suspensions.